Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/12/2022 17 1
Gam-COVID-Vac Emergency use authorization Experimental Vaccine Dec/23/2021 3 1
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Hemin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/13/2021 1 1
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/04/2021 3 0